New York State Assembly

Bill No.:  

 
•  Summary 
 
•  Actions 
 
•  Committee Votes 
 
•  Floor Votes 
 
•  Memo 
 
•  Text 
 
•  LFIN 
 
•  Chamber Video/Transcript 

---

A01055 Summary:

BILL NO	A01055
SAME AS	SAME AS S03347
SPONSOR	Rosenthal L
COSPNSR
MLTSPNSR
Add §32.12, Ment Hyg L
Requires facilities that provide treatment for substance use disorders to have at least one practitioner qualified to administer or prescribe buprenorphine to individuals in their care with substance use disorders related to opioids.

Go to top    

---

A01055 Actions:

BILL NO	A01055
01/13/2023	referred to alcoholism and drug abuse
04/25/2023	reported referred to ways and means
01/03/2024	referred to ways and means

Go to top

---

A01055 Committee Votes:

Committee:ALCOHOLISM AND DRUG ABUSE   Chair:Steck      
DATE:04/25/2023AYE/NAY:12/0  Action: Favorable refer to committee Ways and Means        
Steck
Aye
Brown
Aye
Stirpe
Aye
Brook-Krasny
Aye
Davila
Aye
Gray
Aye
McDonald
Aye
Maher
Aye
Reyes
Excused
Gallagher
Aye
Jackson
Aye
Ardila
Excused
Bores
Aye
Zaccaro
Aye

Go to top

---

A01055 Floor Votes:

Go to top

---

A01055 Text:

 
                STATE OF NEW YORK
        ________________________________________________________________________
 
                                          1055
 
                               2023-2024 Regular Sessions
 
                   IN ASSEMBLY
 
                                    January 13, 2023
                                       ___________
 
        Introduced  by  M.  of  A. L. ROSENTHAL -- read once and referred to the
          Committee on Alcoholism and Drug Abuse
 
        AN ACT to amend the mental hygiene law, in relation to the  availability
          of buprenorphine in opioid treatment programs
 
          The  People of the State of New York, represented in Senate and Assem-
        bly, do enact as follows:
 
     1    Section 1. The mental hygiene law is amended by adding a  new  section
     2  32.12 to read as follows:
     3  § 32.12 Availability of buprenorphine.
     4    Every   facility  licensed  or  authorized  to  provide  services  for
     5  substance use disorders related to  opioids  that  employs  a  qualified
     6  practitioner,  as  determined  by federal law, shall ensure at least one
     7  practitioner in the facility has received an appropriate  waiver  and/or
     8  has completed required training to administer or prescribe buprenorphine
     9  to  individuals  in  their care with a substance use disorder where such
    10  drug is determined appropriate for their treatment.
    11    § 2. This act shall take effect on the one hundred twentieth day after
    12  it shall have become a law.  Effective immediately, the addition, amend-
    13  ment and/or repeal of any rule or regulation necessary for the implemen-
    14  tation of this act on its effective date are authorized to be  made  and
    15  completed on or before such effective date.
 
 
 
 
         EXPLANATION--Matter in italics (underscored) is new; matter in brackets
                              [ ] is old law to be omitted.
                                                                   LBD00691-01-3

Go to top